CatalystWireBeta

Genus

GNS · Main Market · Health Care · mcap £1,490m · 2288.0p

Beta Briefing, track record and signals & risks are not ready for Genus yet.

We follow 964 UK small caps and every one of their announcements – often hundreds per company. 73 companies are already wired into a briefing: browse them.

JNE Partners LLP 16 Jun · 1 notice
4.9% → 5.0%
share price at the notices 2216.0p · now 2288.0p 16 Jun 2026
BlackRock 10 Mar – 14 Sep · 2 notices
5.0% → 5.0%
share price at the notices 2134.0–2740.0p · now 2288.0p 10 Mar 2026 14 Sep 2026
Baillie Gifford & Co. 14 Oct · 1 notice
5.0% → 5.0%
share price at the notices 2655.0p · now 2288.0p 14 Oct 2025

Directors and managers

Last 12 months: bought £100k in 2 trades · no market sales · 14 other transactions (awards, vesting, tax sales, fee and dividend shares)

Own-money trades (bought or sold in the market) say most about what insiders think. Awards, vesting, shares sold to cover tax, fees and dividends taken in shares are part of pay.

DatePersonTransactionSharesPriceValue
29 Jun 26 See notification Buy 2,336 £21.40 £50k
27 Feb 26 See notification Buy 1,728 £28.93 £50k

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note